Christophe Dooms

University Hospitals Leuven

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2025

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Wim Janssens

Professor

Katholieke Universiteit Leuven

BELGIUM

View details

Diether Lambrechts

full professor

KU Leuven

BELGIUM

View details

Els Wauters

Universitaire Ziekenhuizen Leuven

BELGIUM

View details

Marc Gewillig

Head, Prof

BELGIUM

View details

JULIEN MAZIERES

PROFESSOR

FRANCE

View details

Kristina Holmberg

Head of Clinical Biomarkers

Lund University

DENMARK

View details

Witold Rzyman

Chief Surgeon

Medical University of Gdansk

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christophe Dooms

Research Interests

Explore related searches

Contact this professor

Articles (12)

Late Recurrence of Mucinous Adenocarcinoma after Lung Transplantation: A Case Report and Literature Review

Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation

INSIGHT 2: a phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance

Direct EBUS‐guided transtracheal lymphosclerosis for plastic bronchitis after Fontan

Lung volume reduction in emphysema: a pragmatic prospective cohort study

Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host

Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity

Early lung ultrasound assessment for the prognosis of patients hospitalized for COVID-19 pneumonia. A pilot study

Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial

COVID‐19 in lung transplant patients: A case series

Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays’ and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort

Collaborators (7)

Wim Janssens

Diether Lambrechts

Els Wauters

Marc Gewillig

JULIEN MAZIERES

Kristina Holmberg

Witold Rzyman

Make your next move.